Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights
Lantern Pharma and Oregon partner to develop cancer treatment [Yahoo! Finance]
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism [Yahoo! Finance]
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism